YT

Yogesh Tiwari

Active Director Director DIN 10409670
DIN 10409670 First appointment Nov 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Yogesh Tiwari

Data last updated:

Yogesh Tiwari is a Director at Alger Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Alger Pharmaceuticals Private Limited reported revenue of ₹7.4 Lakh (FY 2025).

DIN 10409670
Primary Designation Director
Industry Paper
First Appointment 30 Nov 2023
Oldest Company Age 2 yrs
Largest company Alger Pharmaceuticals Private Limited · ₹7.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Nov 20232023₹7.4 Lakh (FY 2025)Active

Board colleagues of Yogesh Tiwari

Directorship timeline

Open interactive timeline →
Alger Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Yogesh Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Tiwari

Yogesh Tiwari currently holds 1 directorship: Alger Pharmaceuticals Private Limited (Director, since 30 Nov 2023, revenue ₹7.4 Lakh (FY 2025)).

Yogesh Tiwari was first appointed on 30 Nov 2023 as Director at Alger Pharmaceuticals Private Limited.

The current boards of Yogesh Tiwari's companies include Ajeet Pratap Singh (Alger Pharmaceuticals Private Limited), Anurag Sharma (Alger Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available